title: Long-lasting dermatological lesions after tiludronate therapy.
authors.affiliation: Department of Rheumatology, René Descartes University, Cochin Hospital, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Roux
authors.forename: V
authors.initials: V
authors.lastname: Listrat
authors.forename: B
authors.initials: B
authors.lastname: Villette
authors.forename: M
authors.initials: M
authors.lastname: Lessana-Leibowitch
authors.forename: D
authors.initials: D
authors.lastname: Ethgen
authors.forename: C
authors.initials: C
authors.lastname: Pelissier
authors.forename: M
authors.initials: M
authors.lastname: Dougados
authors.forename: B
authors.initials: B
authors.lastname: Amor
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000150:complications; D008875:Middle Aged; D011537:Pruritus / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology*; D016032:Randomized Controlled Trials as Topic; D012867:Skin / Q000187:drug effects / Q000473:pathology*
chemical_list: D000305:Adrenal Cortex Hormones; D004164:Diphosphonates; C058651:tiludronic acid